Skip to content

Prospective Genomics Initiative on Metastatic Epithelial Ovarian Cancer

Prospective Genomics Initiative on Metastatic Epithelial Ovarian Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019469
Enrollment
Unknown
Registered
2018-11-12
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

Case series:Nil

Sponsors

Renji Hospital, School of Medicine, Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Female aged at least 18 years old; (2) Diagnosis of ovarian cancer by imaging and pathological; (3) No antineoplastic treatment was performed before operation; (4) Receive the ovarian cancer surgery in gynecology and obstetrics of Renji Hospital; (5) The patients who voluntarily participate in the research with good compliance; (6) The patients who sign the informed consent and agree to use their data and carry out the drug genome; testing;

Exclusion criteria

Exclusion criteria: (1) Patients who receive other antitumor treatments or previous tumor surgery before entering clinical trial group. (2) Patients with malignant tumors in other locations except ovarian cancer; (3) The patients who are suffering from nervous or mental disorders; (4) The patients who can not follow or describe the responder with poor compliance.

Design outcomes

Primary

MeasureTime frame
overall survival;

Secondary

MeasureTime frame
Progress free survival;

Countries

China

Contacts

Public ContactWen Di

Renji Hospital, School of Medicine, Shanghai Jiaotong University

diwen163@163.com+86 13701642665

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026